Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...
GRACE is very happy to bring to you more videos from our program, Supportive Care in Cancer Treatment. In this video our host, Dr. Arjun Gupta speaks...
GRACE is very excited to bring to you more videos from our program, Supportive Care in Cancer Treatment. Arjun Gupta, MD is the host of this video...
We are very excited to bring to you this new program on supportive care in cancer treatment. In this video, our host Dr. Arjun Gupta speaks with his...
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...
Register Now for the Targeted Therapies Patient Forum
Hello there! I have reached out for your thoughts before and so appreciate your expertise. Thank you!
I have psoriasis (along with my stage IV NSCLC ALK Positive) I am taking Alectinib for the NSCLC. Is it OK to take a biologic like Cosentyx, Stelara, or Humira for my psoriasis while on the TKI Alectinib?
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library.
In this video translation, Dr. Li discusses the current status of Tumor Mutation Burden (TMB).

For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library.
In this video translation, Dr. Li discusses evolving standards for molecular testing in advanced NSCLC.
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library.
In this video translation, Dr. Li discusses the role of immunotherapy in stage lll NSCLC, the Pacific trial and imfinzi.
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library.
In this video translation, Dr. Li discusses the current status of combinations of immunotherapy agents in advanced NSCLC.
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library.
In this video translation, In this video translation, Dr. Li discusses the basics of managing immune related side effects.

For our Mandarin-speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library.
In this video translation, Dr. Li discusses what patients with rapid progression through first line treatment should receive next.

For our Mandarin-speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library.
In this video translation, Dr. Li discusses consolidation radiation after a good response to first-line therapy.

Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.